By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2800 Plymouth Road
NCRC, Building 26
Ann Arbor  Michigan  48220  U.S.A.
Phone: 734-233-3060 Fax: n/a



Start Up

Company News
Lycera Announces Progress In Immuno-Oncology Program Presented At The 2016 AACR Annual Meeting 4/19/2016 10:29:28 AM
Lycera Announces Presentations Of Positive Preclinical Results For Lead Candidate LYC-30937 And For Selective Rho Kinase Inhibitor Program At The 11th Congress Of The European Crohn's And Colitis Organization (ECCO) 3/18/2016 6:26:42 AM
Lycera Announces Celgene Has Exercised Its Option To License Portfolio Of Ex Vivo RORgamma Agonist Compounds Under Global Strategic Collaboration 1/11/2016 8:04:27 AM
Lycera Announces Progress In Immuno-Oncology Program To Be Presented At Society For Immunotherapy Of Cancer (SITC) 2015 Annual Meeting 11/3/2015 7:34:19 AM
Lycera Expands Leadership Team, Appoints Alex G. Howarth As Chief Financial Officer 10/6/2015 6:38:12 AM
Celgene (CELG) Shells Out $82.5 Million in Cash for Portfolio, Option to Buy Lycera 6/9/2015 5:57:31 AM
Lycera Initiates Phase 1 Clinical Trial Of LYC-30937, A First-In-Class Atpase Modulator For Inflammatory Bowel Disease 4/30/2015 6:15:19 AM
Lycera To Present At Immunology 2015, The Annual Meeting Of The American Association Of Immunologists (AAI) 4/8/2015 7:40:02 AM
Lycera Announces Milestone In Merck & Co. (MRK) Collaboration 3/25/2015 6:38:42 AM
Lycera To Present At The 2015 American Association for Cancer Research Annual Meeting 3/19/2015 10:04:18 AM